OQROGet OQRO Pro
Insider trade

Ionis Pharmaceuticals (IONS)EVP Research sold ~$45K

Eric Swayze, EVP Research at Ionis Pharmaceuticals, sold ~$45K of Ionis Pharmaceuticals shares.

~$45K
Approx. value · 1,194 sh @ $37.92
34K
Holds after · shares reported
Traded
Nov 12, 2024
Filed
Nov 14, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 16, 2024InsiderOfficer sold ~$2K of IONS shares in the open market
  2. Nov 12, 2024 · this disclosureInsiderOfficer sold ~$45K of IONS shares in the open market

What came next

  1. Nov 12, 2024Insider · 2 peopleInsiders: 2 sales (~$764K)
  2. Dec 23, 2024Insider · 1 personInsiders: 2 purchases (~$181K)
  3. Jan 16, 2025Insider · 10 peopleInsiders: 12 sales (~$3.0M)
  4. Jan 31, 2025Insider · 7 peopleInsiders: 7 sales (~$705K)
  5. Feb 4, 2025Insider · 2 peopleInsiders: 2 sales (~$1.4M)
  6. Feb 20, 2025InsiderOfficer sold ~$39K of IONS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ionis Pharmaceuticals

For Ionis Pharmaceuticals, OQRO holds 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IONS page.

Other recent filings by Eric Swayze, EVP Research

The full history of Eric Swayze, EVP Research is on the profile page.

How this filing works

Other disclosures at Ionis Pharmaceuticals

Everything OQRO holds on this company is on its IONS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data